The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy ...

Researchers at Roswell Park Comprehensive Cancer Center have shown that hormone-blocking therapies commonly used to treat ...

Johnson & Johnson (J&J) said that an early-stage trial of JNJ-6143 (previously HLD-0915) found that the novel oral Regulated ...

Scientists have discovered vital clues to help predict, more than a decade in advance, which men may develop prostate cancer.

The patient was at a facility in Minneola, Florida, while the surgeon operated remotely from another facility ...

The update replaces ASTRO’s 2018 recommendations to reflect the growing body of evidence showing that hypofractionated ...

Adding darolutamide to standard treatment for aggressive prostate cancer reduced the risk of the disease spreading in an ...

A study of 302 patients found prostate artery embolization significantly improved urinary symptoms, objective parameters, and ...

After a friend divulged perhaps too much information, humorist David Sedaris considers the ramifications of over-sharing – ...

A new alpha-emitting radiopharmaceutical therapy (RPT) for advanced prostate cancer was well tolerated, with no dose-limiting ...

A crowd of South African men ran through the streets of Johannesburg in purple swim briefs to raise awareness about prostate ...

The FDA has expanded its approval of talazoparib in combination with enzalutamide to include men with metastatic androgen ...